Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape향상된 전염성 및/또는 부분 면역 탈출이 있는 SARS-CoV-2 변이체의 인구 영향Article Published on 2021-12-222022-09-11 Journal: Cell [Category] SARS, 변종, [키워드] acquired immunity breakthrough infections build Course COVID-19 effort Epidemic exacerbating explain help immune Immune escape Immunity in some mathematical mathematical model Nonpharmaceutical interventions NPI past phenotype Phenotypes Population Reinfection remained SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants severity Spread strain the epidemic Trajectories trajectory Transmissibility vaccination Vaccine variant variant of concern variants variants of concern VoC wild-type [DOI] 10.1016/j.cell.2021.11.026 PMC 바로가기 [Article Type] Article
Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 델타 변이형 감염은 백신 접종을 받지 않은 사람과 백신을 맞은 사람 모두에서 알파 변이형에 비해 감염성 바이러스의 더 높은 회복률과 관련이 있습니다Major Article Published on 2021-12-182022-09-10 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 진단, 치료제, [키워드] (alpha acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alpha Alpha variant anti-SARS-CoV-2 antibody Antiviral B.1.1.7 B.1.617.2 breakthrough infections Capital Capital Region Cell culture circulating clinical chart Cohort Comorbidities coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 correlated COVID-19 cycle threshold Delta delta variant disease severity greater transmissibility groups IgG IgG levels Immunoglobulin Immunoglobulin G increase in Increases increases in individual Infection infections Infectious virus Lineage Local nasal predominant Region respiratory Result SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 lineage severe acute respiratory syndrome Coronavirus significant increase significantly higher specimens symptomatic the median vaccinated individual vaccinated individuals vaccination variant variants Viral Viral RNA virus VoC Whole genome sequencing [DOI] 10.1093/cid/ciab986 PMC 바로가기 [Article Type] Major Article
Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer암 환자의 세로 SARS-CoV-2 mRNA 백신 유도 체액 면역 반응Article Published on 2021-12-152022-09-11 Journal: Cancer research [Category] MERS, SARS, 진단, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Anti-spike antibody antibody levels Antibody Response B-cell BNT162b2 booster booster vaccination booster vaccinations Breakthrough infection breakthrough infections Cancer clinical care coronavirus COVID-19 illness dose elicit evaluated Follow-up Frequency hematologic humoral responses Immune checkpoint inhibitor Immune checkpoint inhibitors immune responses immunogenicity Immunoglobulin implication longitudinal Longitudinal studies malignancies median mRNA mRNA-1273 Patient patient selection patients Patients with cancer peak levels Population prospective cohort study receiving reduced remained respiratory response SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines sequence severe acute respiratory syndrome Coronavirus severe COVID-19 illness Solid solid tumor solid tumors sustained therapeutic trajectory Treatment Tumor tumors vaccination Vaccinations Vaccine vaccine-induced immune response Variation [DOI] 10.1158/0008-5472.CAN-21-3554 PMC 바로가기 [Article Type] Article
Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional StudyArticle Published on 2021-12-022022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acceptability agency Americans Analysis analyzed Assessing booster booster dose breakthrough infections Chi-square children communicative literacy COVID-19 COVID-19 vaccine COVID-19 vaccines critical literacy effective Factor functional literacy herd immunity individual information less mean score participant Participants proportion significantly higher vaccination Vaccine vaccine booster vaccine confidence index Vaccine hesitancy vaccine literacy Vaccines variants waning immunity was used [DOI] 10.3390/vaccines9121424 PMC 바로가기 [Article Type] Article
Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal StudyPreventive Medicine Published on 2021-11-252022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome Administered affecting age Analysis antibody antibody kinetics Antibody titer AstraZeneca vaccine average AZD1222 binding antibody unit blood sample BMI booster dose Breakthrough infection breakthrough infections ChAdOx1 chadox1 ncov19 vaccine ChAdOx1 vaccine chemiluminescence collected conducted coronavirus Coronavirus disease 2019 COVID vaccine COVID-19 COVID-19 vaccine Covishield dose doses Factor Factors first dose geometric globe healthcare facility Healthcare professional history IgG IgG titer immunoassay Immunoglobulin intramuscularly Kinetics linear mixed model longitudinal material Medical Science men Microparticle mixed model Nurses obese occurred Older overweight pandemic participant Person potential benefit Prospective Research Result SARS-CoV-2 SARS-COV-2 infection second dose seroreversion Seven shown tested the receptor-binding domain the spike protein the vaccine titer vaccination Vaccine vaccine dose viral particle women [DOI] 10.7759/cureus.19879 PMC 바로가기 [Article Type] Preventive Medicine
Are COVID-19 Vaccine Boosters Needed? The Science behind BoostersCOVID-19 백신 부스터가 필요합니까? 부스터의 과학Review Published on 2021-11-242022-09-10 Journal: Journal of Virology [Category] COVID19(2023년), MERS, SARS, 변종, [키워드] booster doses breakthrough infections COVID-19 COVID-19 vaccine distribution dose eligibility Epidemiology global pandemic herd immunity Immunity immunology Increases increases in neutralizing antibody reported Safe SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Science the timing trajectory Vaccine Vaccine-induced immunity Vaccines [DOI] 10.1128/jvi.01973-21 PMC 바로가기 [Article Type] Review
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyMulticenter Study Published on 2021-11-232022-10-04 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 변종, 치료법, [키워드] 95% CI acute respiratory syndrome adjusted odds ratio Alter Anti-spike antibody B.1.617.2 Breakthrough infection breakthrough infections Clinical features cohort study conducted coronavirus COVID-19 COVID-19 pandemic Delta delta variant Diagnosis effective effective vaccine faster group hospital in viral individual individuals Infection mRNA vaccine multicentre objective Older age oxygen supplementation Patient PCR cycle Protein Result retrospective cohort study RNA robust SARS-CoV-2 SARS-COV-2 infection serological serological response severe COVID-19 significantly significantly lower Singapore Spread symptomatic the vaccine threshold value titre titres vaccinated individuals vaccination Vaccine Vaccine breakthrough vaccine strain variants of concern Viral load Virological Virus neutralization wildtype [DOI] 10.1016/j.cmi.2021.11.010 PMC 바로가기 [Article Type] Multicenter Study
COVID-19 Vaccine Boosters: The Good, the Bad, and the UglyArticle Published on 2021-11-092022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] administration African booster dose breakthrough infections characterized conditions Course Coverage COVID-19 COVID-19 vaccine death decrease Efficacy Efficiency effort epidemiological evade Evolution Good Hospitalization Immunity immunology include Infection limit massive vaccinations Neutralizing antibodies offer pandemic Population populations question recommendation Region regions risk SARS-CoV-2 serum antibody severe disease Spread Transmissibility vaccination vaccination rate Vaccine vaccine doses vaccine inequity Vaccine-induced immunity variant variants [DOI] 10.3390/vaccines9111299 PMC 바로가기 [Article Type] Article
COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)Article Published on 2021-11-022022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] age Asymptomatic Breakthrough infection breakthrough infections calculated clinical trials close contact combating Complete Control control group Course COVID-19 COVID-19 vaccine Cycle threshold value Department doses explained Factor first vaccination Health Infection Male sex Measures occurred pandemic Patient patients Public R 2 real-world data risk SARS-CoV-2 pandemic SARS-CoV-2 transmission Sex Symptom the SARS-CoV-2 virus Transmission vaccination virus [DOI] 10.3390/vaccines9111267 PMC 바로가기 [Article Type] Article
Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers예방 접종을 받은 의료 종사자들 사이에서 SARS-CoV-2 변종 B.1.1.7의 전파Article Published on 2021-11-012022-09-11 Journal: Infectious diseases (London, England) [Category] SARS, 변종, [키워드] acceptance acquisition age B.1.1.7 BNT162b2 Breakthrough infection breakthrough infections Cohort concerning COVID-19 COVID-19 outbreak cycle threshold diagnosed with COVID-19 Diagnosis dose effective Efficacy Gender HCW HCWs Health care worker healthcare worker In-hospital measure MOST nasopharyngeal neutralization not differ of BNT162b2 PCR positive Prospective prospective cohort reduced SARS-CoV-2 SARS-CoV-2 variant sera significantly Spread study period Symptom the disease Transmissibility Transmission vaccinated individual vaccinated individuals vaccination vaccination against COVID-19 variant Viral load viral loads were expressed [DOI] 10.1080/23744235.2021.1945139 PMC 바로가기 [Article Type] Article